Vorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the Urothelium - Contacts and Locations

Vorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the Urothelium

This study is ongoing, but not recruiting participants.

Study NCT00363883. Last updated on October 25, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00363883

Locations


United States, California
	City of Hope Comprehensive Cancer Center
	Duarte, California, United States, 91010-3000
	City of Hope Medical Group
	Pasadena, California, United States, 91105
	Contra Costa Regional Medical Center
	Martinez, California, United States, 94553
	Tower Cancer Research Foundation
	Beverly Hills, California, United States, 90211
	University of California Davis Cancer Center
	Sacramento, California, United States, 95817
	USC/Norris Comprehensive Cancer Center and Hospital
	Los Angeles, California, United States, 90033-0804
	Veterans Affairs Outpatient Clinic - Martinez
	Martinez, California, United States, 94553

United States, Pennsylvania
	UPMC Cancer Centers
	Pittsburgh, Pennsylvania, United States, 15232

Sponsors and Collaborators

California Cancer Consortium

National Cancer Institute (NCI)

Investigators


Study Chair:	David I. Quinn, MD	Norris Comprehensive Cancer Center